These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

637 related items for PubMed ID: 8956074

  • 1. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R, Wilkes BC, Chung NN, Lemieux C, Schiller PW.
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [Abstract] [Full Text] [Related]

  • 2. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R, Vogel D, Mrestani-Klaus C, Brandt W, Neubert K, Chung NN, Lemieux C, Schiller PW.
    J Med Chem; 1994 Apr 15; 37(8):1136-44. PubMed ID: 8164255
    [Abstract] [Full Text] [Related]

  • 3. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D, Mannekens E, Diem TN, Verheyden P, Jaspers H, Tóth G, Péter A, Kertész I, Török G, Chung NN, Schiller PW.
    J Med Chem; 1998 Dec 17; 41(26):5167-76. PubMed ID: 9857087
    [Abstract] [Full Text] [Related]

  • 4. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
    Tóth G, Ioja E, Tömböly C, Ballet S, Tourwé D, Péter A, Martinek T, Chung NN, Schiller PW, Benyhe S, Borsodi A.
    J Med Chem; 2007 Jan 25; 50(2):328-33. PubMed ID: 17228874
    [Abstract] [Full Text] [Related]

  • 5. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S, Balboni G, Guerrini R, Tomatis R, Bianchi C, Bryant SD, Cooper PS, Lazarus LH.
    J Med Chem; 1997 Sep 12; 40(19):3100-8. PubMed ID: 9301674
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
    Kramer TH, Davis P, Hruby VJ, Burks TF, Porreca F.
    J Pharmacol Exp Ther; 1993 Aug 12; 266(2):577-84. PubMed ID: 8394911
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS, Murray TF, Aldrich JV.
    J Med Chem; 2004 Jan 15; 47(2):446-55. PubMed ID: 14711314
    [Abstract] [Full Text] [Related]

  • 11. A comprehensive study on the putative δ-opioid receptor (sub)types using the highly selective δ-antagonist, Tyr-Tic-(2S,3R)-β-MePhe-Phe-OH.
    Birkas E, Bakota L, Gulya K, Wen T, Pintar J, Tóth G, Szucs M.
    Neurochem Int; 2011 Aug 15; 59(2):192-201. PubMed ID: 21672586
    [Abstract] [Full Text] [Related]

  • 12. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
    Schiller PW, Weltrowska G, Berezowska I, Nguyen TM, Wilkes BC, Lemieux C, Chung NN.
    Biopolymers; 1999 Aug 15; 51(6):411-25. PubMed ID: 10797230
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S, Kezar HS, Carter RL, Saini SK, Rice KC, Wells JL, Davis P, Xu H, Dersch CM, Bilsky EJ, Porreca F, Rothman RB.
    J Med Chem; 1999 Sep 09; 42(18):3527-38. PubMed ID: 10479286
    [Abstract] [Full Text] [Related]

  • 14. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May 09; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 15. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE, Kazmierski W, Wire WS, Lemcke PK, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1988 Sep 09; 246(3):1018-25. PubMed ID: 2843623
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
    Ioja E, Tóth G, Benyhe S, Tourwe D, Péter A, Tömböly C, Borsodi A.
    Neurosignals; 2005 Sep 09; 14(6):317-28. PubMed ID: 16772734
    [Abstract] [Full Text] [Related]

  • 19. Cyclic enkephalin analogs containing various para-substituted phenylalanine derivatives in place of Tyr1 are potent opioid agonists.
    Weltrowska G, Lemieux C, Chung NN, Schiller PW.
    J Pept Res; 2005 Jan 09; 65(1):36-41. PubMed ID: 15686532
    [Abstract] [Full Text] [Related]

  • 20. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N, Milanov P, Vezenkov L, Pajpanova T, Naydenova E.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):249-56. PubMed ID: 15364002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.